Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received FDA approval for the Android version of its Mobi mobile app.
Q3 2025 Earnings Call Transcript November 6, 2025 Tandem Diabetes Care, Inc. reports earnings inline with expectations.
Automated insulin delivery was improved with improved glycemic control metrics among patients with type 2 diabetes regardless of C-peptide levels.
Over 60% of the students at Simpson College are student-athletes, and balancing classes, practices and competition is part of ...
Pandemic-era subsidies that made Affordable Care Act plans cheaper are set to expire at the end of 2025. Millions of Americans will face significantly higher health insurance costs or lose coverage ...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced that the ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback